A
RYTM icon

AlphaQuest’s Rhythm Pharmaceuticals RYTM Stock Holding History

AlphaQuest’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,508
Closed -$161K – 1690
2025
Q4 		$161K Buy
1,508
+117
+8% +$12.4K 0.01% 1544
2025
Q3 		$140K Sell
1,391
-79
-5% -$7.33K 0.01% 1578
2025
Q2 		$92.9K Sell
1,470
-5,137
-78% -$315K 0.01% 1454
2025
Q1 		$350K Buy
6,607
+6,606
+660,600% +$367K 0.04% 690
2024
Q4 		$56 Sell
1
-9,166
-100% -$506K ﹤0.01% 1639
2024
Q3 		$480K Buy
9,167
+7,505
+452% +$360K 0.04% 670
2024
Q2 		$68.2K Buy
1,662
+1,391
+513% +$55.5K 0.01% 1024
2024
Q1 		$11.7K Buy
+271
New +$11.9K ﹤0.01% 1070

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

AlphaQuest's RYTM Position: Q1 2026 in Review

AlphaQuest sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 1,508 shares — an estimated $161K sold.

AlphaQuest first reported a position in RYTM in Q1 2024 and held it in 8 quarters. The position peaked at $480K in Q3 2024. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • AlphaQuest reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,508 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $161K.
  • AlphaQuest first reported a position in Rhythm Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Rhythm Pharmaceuticals position peaked at $480K in Q3 2024.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.